Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.

Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group. JAMA. 1995 Mar 22-29; 273(12):934-41.

View in: PubMed

subject areas

Adult
Aged
Analysis of Variance
Antibodies, Monoclonal
APACHE
Cause of Death
Double-Blind Method
Female
Humans
Infusions, Intravenous
Male
Middle Aged
Prospective Studies
Shock, Septic
Survival Analysis
Systemic Inflammatory Response Syndrome
Tumor Necrosis Factor-alpha

authors with profiles

Robert A. Balk